Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Instagram Outage Disrupts Thousands of U.S. Users 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
TriCore Contact:
|
|||
Dr. Nick Dayan
Chief Administrative Officer
(505) 938-8991
TriCore Announces Dr. Michael Crossey as Chief Executive Officer & President
For Immediate Release (Albuquerque, New Mexico) - March 6, 2018 – TriCore Reference Laboratories is pleased to announce that the board of directors has appointed Michael Crossey, MD, PhD, to the position of CEO and president, effective immediately.
Dr. Crossey’s appointment is a clear reflection of the company’s current state: Ready to take on the future! Robin Divine, chair of TriCore’s board of directors, stated: “Enormous opportunity for TriCore lies ahead. We couldn’t be happier with Dr. Crossey accepting this position and moving us down the path of continued success.”
For the past 20 years since TriCore’s inception, Dr. Crossey has served the organization in various capacities, from pathologist to chief medical officer to interim chief executive officer. He brings decades of experience and internationally recognized expertise in clinical laboratory medicine to the company.
Says Dr. Crossey of his new position: “I'm honored, and I'm grateful to the board for the opportunity to lead this exceptional organization of creative, dedicated and talented professionals."
###
TriCore Reference Laboratories is an independent, not-for-profit, clinical reference laboratory founded and headquartered in Albuquerque, New Mexico, co-sponsored by Presbyterian Healthcare Services and University of New Mexico Health Sciences Center. TriCore provides over 2,900, full-service, state-of-the-art laboratory tests to healthcare professionals and their patients. TriCore also provides analytics and research services, supporting healthcare and scientific organizations worldwide.
For more information, visit tricore.org.
Attachment:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/68207f80-51fb-4664-84de-80bee403f3fc
Nick Dayan TriCore Reference Laboratories 5059388991 [email protected]
